Alvotech Ordinary Shares (ALVO) Stock: Buy, Sell, or Hold?
ALVO - Alvotech Ordinary Shares
$5.29
0.05 (0.95%)
▲
5d:
-1.67%
30d:
+31.92%
90d:
+25.36%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 12, 2026
0d
Get Alerted When ALVO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ALVO shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ALVO shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$5.15
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$3.20
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ALVO is currently trading at $5.29, which is considered extended relative to its 30-day fair value range of $3.94 to $5.20. From a valuation perspective, the stock is trading at a premium (Forward PE: 23.2) compared to its historical average (16.1). At these levels, the market is pricing in 12.8% annual earnings growth.
Technical Outlook: Technically, ALVO is in a strong uptrend. Immediate support is located at $4.82, while resistance sits at $5.47.
Market Sentiment: ALVO scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $6.00 (+13.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ALVO is in a strong uptrend. Immediate support is located at $4.82, while resistance sits at $5.47.
Market Sentiment: ALVO scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $6.00 (+13.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.94 -
$5.20
Company Quality Score
35/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
29.5%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($6.00)
- BULLISH: Expecting earnings turnaround to 12.8% growth with -38.9% revenue growth
- WARNING: Composite score 35/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.94 -
$5.20
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.82
Resistance Level
$5.47
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
23.17
Wall Street Target
$6.00
(+13.4%)
Revenue Growth (YoY)
-38.9%
Earnings Growth (YoY)
-99.0%
Profit Margin
-36.3%
Valuation Premium vs History
+12.8% premium
PE vs Historical
23.2 vs 16.1
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+12.8%
(market-implied from PE analysis)
1-Year Target
$5.97
(+13%)
2-Year Target
$6.73
(+27%)
3-Year Target
$7.59
(+44%)
3-Yr Target (if PE normalizes)
(PE: 23→16)
PE COMPRESSION
$5.28
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: September 12, 2026 8:37 PM ET
Data refreshes hourly during market hours. Next update: 9:37 PM
Data refreshes hourly during market hours. Next update: 9:37 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALVO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$212 | 60 HOLD |
|
LQDA
Liquidia Technologies Inc |
STRONG BUY
10 analysts |
$108 | 70 BUY |
|
INDV
Indivior PLC Ordinary Sh… |
STRONG BUY
7 analysts |
$49 | 69 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$108 | 46 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$664 | 47 HOLD |
